Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence

Molecular Microbiology

Volumn 64, Issue 3, 2007, Pages 771-781

  Moyrand, Frédérique ^a   Fontaine, Thierry ^a   Janbon, Guilhem ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPIMERASE; GALACTOSE; GALACTOXYLOMANNAN; GLUCOSE TRANSPORTER; GLUCURONOXYLOMANNAN; POLYSACCHARIDE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GALACTOSE; URIDINE DIPHOSPHATE GLUCOSE;

ARTICLE; BIOSYNTHESIS; CRYPTOCOCCUS NEOFORMANS; FUNGAL STRAIN; FUNGAL VIRULENCE; GENE CASSETTE; GENE CONSTRUCT; GENE DELETION; INFECTION; METABOLISM; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SYNTHESIS; TEMPERATURE SENSITIVITY; WILD TYPE;

FILOBASIDIELLA NEOFORMANS; MUS;

EID: 34247495564     PISSN: 0950382X     EISSN: 13652958     Source Type: Journal    
DOI: 10.1111/j.1365-2958.2007.05695.x     Document Type: Article

References (47)

1. Bates, S., Hughes, H.B., Munro, C.A., Thomas, W.P., MacCallum, D.M., Bertram, G., et al. (2006) Outer chain N-glycans are required for cell wall integrity and virulence of Candida albicans. J Biol Chem 281 : 90 98.
2. Bose, I., Reese, A.J., Ory, J.J., Janbon, G. Doering, T.L. (2003) A yeast under cover: the capsule of Cryptococcus neoformans. Eukaryot Cell 2 : 655 663.
3. Bruno, V.M. Mitchell, A.P. (2004) Large-scale gene function analysis in Candida albicans. Trends Microbiol 12 : 157 161.
4. Casadevall, A. Scharff, M.D. (1991) The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies. J Exp Med 174 : 151 160.
5. Casadevall, A. Perfect, J.R. (1998) Cryptococcus Neoformans. Washington, DC : American Society for Microbiology Press.
6. Chaka, W., Verheul, A.F.M., Vaishnav, V.V., Cherniak, R., Scharringa, J., Verhoef, J., et al. (1997) Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells. Infect Immun 65 : 272 278.
7. Chang, Y.C. Kwon-Chung, K.J. (1994) Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol Cell Biol 14 : 4912 4919.
8. Chang, Y.C. Kwon-Chung, K.J. (1998) Isolation of the third capsule-associated gene CAP60, required for virulence in Cryptococcus neoformans. Infect Immun 66 : 2230 2236.
9. Chang, Y.C. Kwon-Chung, K.J. (1999) Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans. J Bacteriol 181 : 5636 5643.
10. Chang, Y.C., Penoyer, L.A. Kwon-Chung, K.J. (1996) The second capsule gene of Cryptococcus neoformans, CAP64, is essential for virulence. Infect Immun 64 : 1977 1983.
11. Chang, Y.C., Stins, M.F., Caffery, M.J., Miller, G.F., Pare, D.R., Dam, T., et al. (2004) Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect Immun 72 : 4985 4995.
12. Charlier, C., Chretien, F., Baudrimont, M., Mordelet, E., Lortholary, O. Dromer, F. (2005) Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am J Pathol 166 : 421 432.
13. Cormack, B.P., Ghori, N. Falkow, S. (1999) An adhesin of the yeast pathogen Candida glabrata mediating adherence to human epithelial cells. Science 285 : 578 582.
14. D'Souza, C.A., Alspaugh, J.H., Yue, C., Harashima, T., Cox, G.M., Perfect, J.R. Heitman, J. (2001) Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans. Mol Cell Biol 21 : 3179 3191.
15. Dromer, F., Salamero, J., Contrepois, A., Carbon, C. Yeni, P. (1987) Production, characterization, and antibody specificity of a mouse antibody reactive with Cryptococcus neoformans capsular polysaccharide. Infect Immun 55 : 742 748.
16. Ellerbroek, P.M., Lefeber, D.J., van Veghel, R., Scharringa, J., Brouwer, E., Gerwig, G.J., et al. (2004) O-acetylation of cryptococcal capsular glucuronoxylomannan is essential for interference with neutrophil migration. J Immunol 173 : 7513 7520.
17. García-Rivera, J., Chang, Y.C., Kwon-Chung, K.J. Casadevall, A. (2004) Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan. Eukaryot Cell 3 : 385 392.
18. Giaever, G., Chu, A.M., Ni, L., Connelly, C., Riles, L., Veronneau, S., et al. (2002) Functional profiling of the Saccharomyces cerevisiae genome. Nature 418 : 387 391.
19. Holden, H.M., Rayment, I. Thoden, J.B. (2003) Structure and function of enzymes of the Leloir pathway for galactose metabolism. J Biol Chem 278 : 43885 43888.
20. Hua, J.H., Meyer, J.D. Lodge, J.K. (2000) Development of positive markers for the fungal pathogen, Cryptococcus neoformans. Clin Diagn Lab Immunol 7 : 125 128.
21. Hunt, T.A., Kooi, C., Sokol, P.A. Valvano, M.A. (2004) Identification of Burkholderia cenocepacia genes required for bacterial survival in vivo. Infect Immun 72 : 4010 4022.
22. Ikeda, R., Nishimura, S., Nishikawa, A. Shinoda, T. (1996) Production of agglutinating monoclonal antibody against antigen 8 specific for Cryptococcus neoformans serotype D. Clin Diagn Lab Immunol 3 : 89 92.
23. James, P.G. Cherniak, R. (1992) Galactoxylomannans of Cryptococcus neoformans. Infect Immun 60 : 1084 1088.
24. Janbon, G. (2004) Cryptococcus neoformans capsule biosynthesis and regulation. FEMS Yeast Res 4/8 : 765 771.
25. Janbon, G., Himmelreich, U., Moyrand, F., Improvisi, L. Dromer, F. (2001) Cas1p is a membrane protein necessary for the O-acetylation of the Cryptococcus neoformans capsular polysaccharide. Mol Microbiol 42 : 453 469.
26. Kozel, T.R., Levitz, S.M., Dromer, F., Gates, M.A., Thorkildson, P. Janbon, G. (2003) Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O-acetylation or xylosyl side chains. Infect Immun 71 : 2868 2875.
27. Lee, N. Janbon, G. (2006) Techniques and strategies for studying virulence factors in Cryptococcus neoformans. In Medical Mycology: Cellular and Molecular Techniques. Kavanagh, K. (ed.). Chichester : Wiley & Sons, pp. 275 304.
28. Loftus, B., Fung, E., Roncaglia, P., Rowley, D., Amedeo, P., Bruno, D., et al. (2005) The genome and transcriptome of Cryptococcus neoformans, a basidiomycetous fungal pathogen of humans. Science 307 : 1321 1324.
29. Logan, S.M., Conlan, J.W., Monteiro, M.A., Wakarchuk, W.W. Altman, E. (2000) Functional genomics of Helicobacter pylori: identification of a beta-1,4 galactosyltransferase and generation of mutants with altered lipopolysaccharide. Mol Microbiol 35 : 1156 1167.
30. McFadden, D.C., De Jesus, M. Casadevall, A. (2006) The physical properties of the capsular polysaccharides from Cryptococcus neoformans suggest features for capsule construction. J Biol Chem 281 : 1868 1875.
31. Mille, C., Janbon, G., Delplace, F., Ibata-Ombetta, S., Gaillardin, C., Strecker, G., et al. (2004) Inactivation of CaMIT1 inhibits Candida albicans phospholipomannan beta-mannosylation, reduces virulence, and alters cell wall protein beta-mannosylation. J Biol Chem 279 : 47952 47960.
32. Missall, T.A., Pusateri, M.E., Donlin, M.J., Chambers, K.T., Corbett, J.A. Lodge, J.K. (2006) Posttranslational, translational, and transcriptional responses to nitric oxide stress in Cryptococcus neoformans: implications for virulence. Eukaryot Cell 5 : 518 529.
33. Moyrand, F. Janbon, G. (2004) UGD1 encoding the Cryptococcus neoformans UDP-glucose dehydrogenase is essential for growth at 37°C and for capsule biosynthesis. Eukaryot Cell 3 : 1601 1608.
34. Moyrand, F., Klaproth, B., Himmelreich, U., Dromer, F. Janbon, G. (2002) Isolation and characterization of capsule structure mutant strains of Cryptococcus neoformans. Mol Microbiol 45 : 837 849.
35. Moyrand, F., Chang, Y.C., Himmelreich, U., Kwon-Chung, K.J. Janbon, G. (2004) Cas3p belongs to a seven member family of capsule structure designer proteins. Eukaryot Cell 3 : 1513 1524.
36. Nobile, C.J. Mitchell, A.P. (2005) Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr Biol 15 : 1150 1155.
37. Pericolini, E., Cenci, E., Monari, C., De Jesus, M., Bistoni, F., Casadevall, A. Vecchiarelli, A. (2006) Cryptococcus neoformans capsular polysaccharide component galactoxylomannan induces apoptosis of human T-cells through activation of caspase-8. Cell Microbiol 8 : 267 275.
38. Roberts, I.A. (1996) The biochemistry and genetics of capsular polysaccharide production in bacteria. Annu Rev Microbiol 50 : 285 315.
39. Roberts, G.D., Horstmeier, C.D., Land, G.A. Foxworth, J.H. (1978) Rapid urea broth test for yeasts. J Clin Microbiol 7 : 584 588.
40. Sawardeker, J.S., Sloneker, J.H. Jeanes, A. (1965) Quantitative determination of monosaccharides as their alditol acetates by gas liquid chromatography. Anal Biochem 37 : 1602 1604.
41. Seifert, G.J., Barber, C., Wells, B., Dolan, L. Roberts, K. (2002) Galactose biosynthesis in Arabidopsis: genetic evidence for substrate channeling from UDP-D-galactose into cell wall polymers. Curr Biol 12 : 1840 1845.
42. Sherman, F. (1992) Getting started with yeast. In Guide to Yeast Genetics and Molecular Biology, Vol. 194. Guthrie, C. Fink, G.R. (eds). San Diego, CA : Academic Press, pp. 3 21.
43. Späth, G.F., Lye, L.F., Segawa, H., Sacks, D.L., Turco, S.J. Beverley, S.M. (2003) Persistence without pathology in phosphoglycan-deficient Leishmania major. Proc Natl Acad Sci USA 301 : 1241 1243.
44. Vaishnav, V.V., Bacon, B.E., O'Neill, M. Cherniak, R. (1998) Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67. Carbohydr Res 306 : 315 330.
45. Van de Moer, A., Salhi, S.L., Cherniak, R., Pau, B., Garrigues, M.L. Bastide, J.M. (1990) An anti-Cryptococcus neoformans monoclonal antibody directed against galactoxylomannan. Res Immunol 141 : 33 42.
46. Vecchiarelli, A. (2000) Immunoregulation by capsular components of Cryptococcus neoformans. Med Mycol 38 : 407 417.
47. Walton, F.J., Idnurm, A. Heitman, J. (2005) Novel gene functions required for melanization of the human pathogen Cryptococcus neoformans. Mol Microbiol 57 : 1381 1396.